Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Jan. 30, 2022			143,964,000
Beginning balance at Jan. 30, 2022		$ 1,664,207	$ 1,440	$ 600,222	$ 1,074,084	$ (10,828)	$ (711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		1,127,904			1,127,904
Foreign currency translation adjustments		(3,572)				(3,572)
Change in fair value of derivative financial instruments, net of tax		932				932
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(341)				(341)
Release of stock-based awards (in shares)	[1]		1,336,000
Release of stock-based awards	[1]	(81,290)	$ 14	(80,932)			(372)
Repurchases of common stock (in shares)			(12,847,000)
Repurchases of common stock		(880,038)	$ (129)	(36,069)	(843,840)
Reissuance of treasury stock under stock-based compensation plans	[1]	0		(344)			344
Stock-based compensation expense		89,578		89,578
Dividends declared		(216,329)			(216,329)
Ending balance (in shares) at Jan. 29, 2023			132,453,000
Ending balance at Jan. 29, 2023		1,701,051	$ 1,325	572,455	1,141,819	(13,809)	(739)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		949,762			949,762
Foreign currency translation adjustments		(999)				(999)
Change in fair value of derivative financial instruments, net of tax		160				160
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(904)				(904)
Release of stock-based awards (in shares)	[1]		1,075,000
Release of stock-based awards	[1]	(52,831)	$ 11	(52,641)			(201)
Repurchases of common stock (in shares)	[2]		(5,227,000)
Repurchases of common stock	[2]	(315,493)	$ (52)	(15,456)	(298,985)		(1,000)
Reissuance of treasury stock under stock-based compensation plans	[1]	0		(334)	(180)		514
Stock-based compensation expense		83,936		83,936
Dividends declared		$ (236,821)			(236,821)
Ending balance (in shares) at Jan. 28, 2024		128,301,000	128,301,000
Ending balance at Jan. 28, 2024		$ 2,127,861	$ 1,284	587,960	1,555,595	(15,552)	(1,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		1,125,251			1,125,251
Foreign currency translation adjustments		(6,136)				(6,136)
Change in fair value of derivative financial instruments, net of tax		1				1
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		94				94
Release of stock-based awards (in shares)	[1]		765,000
Release of stock-based awards	[1]	(94,214)	$ 7	(93,994)			(227)
Repurchases of common stock (in shares)	[2]		(5,941,000)
Repurchases of common stock	[2]	(814,400)	$ (59)	(18,373)	(795,968)
Reissuance of treasury stock under stock-based compensation plans	[1]	0		(1,218)			1,218
Stock-based compensation expense		97,210		97,210
Dividends declared		$ (293,248)			(293,248)
Ending balance (in shares) at Feb. 02, 2025		123,125,000	123,125,000
Ending balance at Feb. 02, 2025		$ 2,142,419	$ 1,232	$ 571,585	$ 1,591,630	$ (21,593)	$ (435)

[1] Amounts are shown net of shares withheld for associate taxes.

[2] Repurchases of common stock include accrued excise taxes of $6.9 million and $2.5 million as of February 2, 2025 and January 28, 2024, respectively, which is recorded in retained earnings.